Compare Home Depot Inc (HD) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Medtronic PLC — how do they compare? Home Depot Inc trades at $295.98 (market cap $285.11B), while Medtronic PLC trades at $87.69 (market cap $109.38B). The key difference: Home Depot Inc is far larger — about 2.6× Medtronic PLC's market cap, and Medtronic PLC pays the higher dividend (3.37%). Which is the better fit depends on your goals — on Pluang, investors hold Home Depot Inc for 139 Days and Medtronic PLC for 63 Days on average.
| HD | MDT | |
|---|---|---|
Market Cap | $285.11B | $109.38B |
Volume | 5,334,053 | 55,890,185 |
Sector | Consumer Cyclical | Health |
52-Week High | $391.90 | $105.35 |
52-Week Low | $281.15 | $73.75 |
Typical Hold Time | 139 Days | 63 Days |
Enterprise Value | $345.59B | $128.71B |
Dividend Yield | 3.26% | 3.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $295.47, up 3.06% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $159.51B in 2025, with net income of $14.81B and a net margin of 8.41%. Recent quarterly earnings have consistently beaten expectations, including Q2 2026 EPS of $4.92 versus $4.73 expected. Cash flow from operations remains strong at $19.81B in 2025, though net cash flow was negative due to significant investing outlays. The stock is near its 52-week low, with key support at $282.
The outlook for HD is mixed; strong Pro segment demand and housing tailwinds support long-term growth, but near-term headwinds include weak big-ticket demand and margin pressure. Analyst consensus is bullish with a $379.93 price target, yet rising mortgage rates and competitive pressures pose risks. Investment appeal hinges on execution in a challenging housing market.
Medtronic (MDT) trades at $87.75, up 0.76% on the day, with strong analyst support (60.78% buy ratings) and a $97.80 consensus price target suggesting 11.4% upside. The stock shows consistent earnings beats in recent quarters with Q3 2026 results pending, while technical indicators signal bearish momentum despite oversold RSI readings. Recent positive developments include FDA clearances for new medical technologies and a 49-year dividend growth streak with a current 3.2% yield.
MDT presents a compelling value opportunity with reasonable valuation multiples (P/E 21.06, P/S 2.93) and improving fundamentals, though technical weakness and competitive pressures warrant caution. The company's revenue growth acceleration to $33.54B in 2025 and strong cash flow generation support the dividend sustainability, while debt levels have increased to 31.11% of assets, representing a key monitoring point for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
